Stock NOVO B NOVO NORDISK A/S
Add to a list
To use this feature you must be a member
Log inSign up

News Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Market Closed - Nasdaq Copenhagen
Other stock markets
 10:59:31 2024-05-07 am EDT 		After market 11:20:00 am
882.6 DKK +3.66% Intraday chart for Novo Nordisk A/S 883 +0.05%
05:48pm Moody’s Revises Novo Nordisk Outlook, Affirms Ratings on Robust Earnings Growth MT
03:56pm NOVO NORDISK : Barclays remains its Buy rating ZD

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Moody’s Revises Novo Nordisk Outlook, Affirms Ratings on Robust Earnings Growth
MT
NOVO NORDISK : Barclays remains its Buy rating
ZD
Novo Nordisk Buys DKK5.4 Billion of Shares From Novo Holdings Under Buyback
MT
Trading in Novo Nordisk shares by board members, executives and associated persons
GL
Novo Nordisk A/S - share repurchase programme
GL
Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
GL
Ventus Therapeutics Announces First Participant Dosed in Clinical Study with an NLRP3 Inhibitor Licensed Exclusively to Novo Nordisk
AQ
Wait, Are Rate Cuts In Late-Summer Back On The Table?
DJ
NOVO NORDISK : UBS sticks Neutral
ZD
Global health heavyweights team up for climate, disease funding
RE
Novo Nordisk A/S (CPSE:NOVO B) cancelled the acquisition of an unknown stake in Healthium Medtech Limited from Apax Partners LLP.
CI
News Highlights : Top Company News of the Day - Friday at 5 PM ET
DJ
News Highlights : Top Company News of the Day - Friday at 7 PM ET
DJ
Health Care Climbs as Amgen Surges on Obesity-Drug Plans - Health Care Roundup
DJ
News Highlights : Top Company News of the Day - Friday at 3 PM ET
DJ
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GL
News Highlights : Top Company News of the Day - Friday at 1 PM ET
DJ
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition
MT
Novo Nordisk: share price falls, analyst adjusts target
CF
Catalent, Novo Nordisk Antitrust Review Extended by FTC
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NOVO B Stock
  4. News Novo Nordisk A/S
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW